Right there with you on the buying opportunity. It does appear the company by their actions agrees with you as well but I would rather see an acquisition bidding beginning at a $1+ then at .40. Looks like FDA approves by 2019!
Right there with you on the buying opportunity. It does appear the company by their actions agrees with you as well but I would rather see an acquisition bidding beginning at a $1+ then at .40. Looks like FDA approves by 2019!